
ZHENGYE BIOTECHNOLOGY-A
ZYBT · NASDAQ
Updated at 2026-10-17 21:28:14
- Today's High
- $1.57
- Today’s Low
- $1.38
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.50
- Previous Close
- $1.40
- Volume
- 81.28K
- Market Cap
- $40.43M
- P/E Ratio
- --
- EPS
- $-1.93
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- DRUG MANUFACTURERS - SPECIALTY & GENERIC
- Headquarters
- NO.1 LIANMENG ROAD, JILIN, CHINA
- Country
- CN
- Listing Date
- 2025-01-07
- Fiscal Year End
- December
- Shares Outstanding
- 29.73M
- CIK
- 0001975641
- Website
- ir.jlzybio.com
Zhengye Biotechnology Holding Limited (Ticker: ZYBT) is an innovative biotechnology firm specializing in the development and commercialization of advanced biopharmaceutical products aimed at addressing critical medical needs. With a robust pipeline and proprietary technologies, ZYBT is well-positioned to enhance treatment outcomes across multiple therapeutic areas. The company's commitment to rigorous research and development, coupled with a focus on quality and innovation, underscores its potential for sustainable growth and value creation for investors in the competitive biotechnology landscape.
Financial Metrics
Revenue
2026-03-31
$53.03M
2025-09-30
$27.01M
Operating Expenses
2026-03-31
$45.26M
2025-09-30
$23.05M
Net Income
2026-03-31
-$47.22M
2025-09-30
-$24.05M
Net Profit Margin
2026-03-31
-89.04%
2025-09-30
-89.04%
Earnings Per Share
2026-03-31
--
2025-09-30
$-0.46
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-03-31
-$27.4M
2025-09-30
-$13.96M
Effective Tax Rate
2026-03-31
-40.1%
2025-09-30
-40.1%
| Item | 2026-03-31 | 2025-09-30 |
|---|---|---|
| Revenue | $53.03M | $27.01M |
| Operating Expenses | $45.26M | $23.05M |
| Net Income | -$47.22M | -$24.05M |
| Net Profit Margin | -89.04% | -89.04% |
| Earnings Per Share | -- | $-0.46 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$27.4M | -$13.96M |
| Effective Tax Rate | -40.1% | -40.1% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.